1. Home
  2. ALT vs MVBF Comparison

ALT vs MVBF Comparison

Compare ALT & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MVBF
  • Stock Information
  • Founded
  • ALT 1997
  • MVBF 1997
  • Country
  • ALT United States
  • MVBF United States
  • Employees
  • ALT N/A
  • MVBF 453
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MVBF Major Banks
  • Sector
  • ALT Health Care
  • MVBF Finance
  • Exchange
  • ALT Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • ALT 292.8M
  • MVBF 282.7M
  • IPO Year
  • ALT N/A
  • MVBF N/A
  • Fundamental
  • Price
  • ALT $3.61
  • MVBF $22.75
  • Analyst Decision
  • ALT Strong Buy
  • MVBF Buy
  • Analyst Count
  • ALT 6
  • MVBF 4
  • Target Price
  • ALT $18.20
  • MVBF $24.50
  • AVG Volume (30 Days)
  • ALT 3.5M
  • MVBF 87.1K
  • Earning Date
  • ALT 08-15-2025
  • MVBF 07-28-2025
  • Dividend Yield
  • ALT N/A
  • MVBF 3.06%
  • EPS Growth
  • ALT N/A
  • MVBF N/A
  • EPS
  • ALT N/A
  • MVBF 1.29
  • Revenue
  • ALT $20,000.00
  • MVBF $143,378,000.00
  • Revenue This Year
  • ALT N/A
  • MVBF N/A
  • Revenue Next Year
  • ALT $346,228.97
  • MVBF $14.75
  • P/E Ratio
  • ALT N/A
  • MVBF $17.23
  • Revenue Growth
  • ALT N/A
  • MVBF N/A
  • 52 Week Low
  • ALT $2.90
  • MVBF $15.59
  • 52 Week High
  • ALT $11.16
  • MVBF $25.13
  • Technical
  • Relative Strength Index (RSI)
  • ALT 34.75
  • MVBF 42.15
  • Support Level
  • ALT $3.58
  • MVBF $22.14
  • Resistance Level
  • ALT $4.39
  • MVBF $24.11
  • Average True Range (ATR)
  • ALT 0.19
  • MVBF 0.79
  • MACD
  • ALT -0.00
  • MVBF -0.34
  • Stochastic Oscillator
  • ALT 4.65
  • MVBF 2.98

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

Share on Social Networks: